184 related articles for article (PubMed ID: 29777095)
1. Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR).
Liao W; Liu J; Zhang D; Huang W; Chen R
Med Sci Monit; 2018 May; 24():3283-3292. PubMed ID: 29777095
[TBL] [Abstract][Full Text] [Related]
2. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
[TBL] [Abstract][Full Text] [Related]
3. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
4. Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway.
Yao S; Wang X; Li C; Zhao T; Jin H; Fang W
Tumour Biol; 2016 Aug; 37(8):10247-56. PubMed ID: 26831667
[TBL] [Abstract][Full Text] [Related]
5. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
[TBL] [Abstract][Full Text] [Related]
6. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.
Rajendran P; Ong TH; Chen L; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Hui KM; Sethi G
Clin Cancer Res; 2011 Mar; 17(6):1425-39. PubMed ID: 21131551
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
8. Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity.
Zhou Y; Li M; Yu X; Liu T; Li T; Zhou L; Liu W; Li W; Gao F
Int J Biol Sci; 2018; 14(11):1521-1534. PubMed ID: 30263005
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
[TBL] [Abstract][Full Text] [Related]
10. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
Dai W; Wang F; Lu J; Xia Y; He L; Chen K; Li J; Li S; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Abudumijiti H; Chen R; Zhang R; Zhou L; Zhou Z; Zhu R; Yang J; Wang C; Zhang H; Zhou Y; Xu L; Guo C
Oncotarget; 2015 May; 6(15):13703-17. PubMed ID: 25938543
[TBL] [Abstract][Full Text] [Related]
11. Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation.
Moon DO; Kim MO; Choi YH; Hyun JW; Chang WY; Kim GY
Cancer Lett; 2010 Feb; 288(2):204-13. PubMed ID: 19643530
[TBL] [Abstract][Full Text] [Related]
12. Antitumor Effect of Morusin via G1 Arrest and Antiglycolysis by AMPK Activation in Hepatocellular Cancer.
Cho AR; Park WY; Lee HJ; Sim DY; Im E; Park JE; Ahn CH; Shim BS; Kim SH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638959
[TBL] [Abstract][Full Text] [Related]
13. Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2.
Zhang H; Du X; Sun TT; Wang CL; Li Y; Wu SZ
Oncol Rep; 2017 Mar; 37(3):1765-1771. PubMed ID: 28098871
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.
Gopalan B; Narayanan K; Ke Z; Lu T; Zhang Y; Zhuo L
Biomaterials; 2014 Aug; 35(26):7479-87. PubMed ID: 24912819
[TBL] [Abstract][Full Text] [Related]
15. Galangin suppresses hepatocellular carcinoma cell proliferation by reversing the Warburg effect.
Wang Y; Lin B; Li H; Lan L; Yu H; Wu S; Wu J; Zhang H
Biomed Pharmacother; 2017 Nov; 95():1295-1300. PubMed ID: 28938520
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2‑mediated glycolysis.
Gao F; Li M; Liu WB; Zhou ZS; Zhang R; Li JL; Zhou KC
Oncol Rep; 2015 Mar; 33(3):1533-9. PubMed ID: 25591943
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
18. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
19. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
[TBL] [Abstract][Full Text] [Related]
20. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]